Lower-sodium reformulation is moving closer to ingredient-scale manufacturing. SALTWELL Group has opened a new Chile facility to increase output, strengthen supply, and support food manufacturers reducing sodium without giving up functionality or clean-label positioning.
Magtein is using Vitafoods Europe to sharpen its scientific positioning. ThreoTech plans to put fresh clinical results, delivery-format strategy, and commercial market access in front of formulators as the magnesium category becomes more segmented.
Sensient is committing new capital to natural colour manufacturing in St Louis. The expansion reflects how quickly reformulation pressure is turning colour from a marketing issue into a production, sourcing, and process challenge.
Celleste Bio has moved cultured cocoa butter closer to scale. Milk chocolate bars made with its ingredient by Mondelēz now put the technology into a more practical discussion about cost, functionality, and future supply resilience.
Kerry has opened expanded lactase capacity in Carrigaline, County Cork. The move lifts industrial-scale enzyme output for lactose-free and reduced-sugar dairy as processors look for faster commercialisation, steadier supply, and tighter process support across multiple markets.
Ornua has reported stronger 2025 results as Kerrygold passed $1 billion in US retail sales, giving the co-op fresh momentum in premium dairy despite continued volatility in milk markets, energy costs, and global trade.
Solar Foods has secured a US patent covering the production process for Solein, reinforcing the company’s intellectual-property position as it plans a major expansion in capacity for its air-based protein ingredient.
New UK research suggests replacing processed meat with plant-based alternatives can improve fibre, saturated fat, and salt intake, but inconsistent micronutrient fortification remains a weakness for manufacturers seeking stronger nutritional parity.
Barry Callebaut lifted recurring net profit in the first half, but weaker volumes, cocoa-market overcapacity, and supply disruption pushed operating earnings lower and forced a downgrade to its full-year outlook.
Arla is taking GLP-1 companion dairy concepts to Barcelona. Smaller, protein-dense formats are moving quickly from niche nutrition into mainstream dairy development.